IP Library Granted Patent US 10,167,467
Granted Patent B2
US 10,167,467 · App. 15/410,249 · Granted Jan 1, 2019

Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,167,467
App. No.
15/410,249
Granted
Jan 1, 2019
Kind
B2
Abstract

The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.

Claims (8)

1. A composition comprising mipomersen and eicosapentaenoic acid, wherein the composition comprises at least about 80%, by weight of all fatty acids (and/or derivatives thereof) present, eicosapentaenoic acid, and no more than about 20%, by weight of all fatty acids (and/or derivatives thereof) present, docosahexaenoic acid or ester thereof.

2. The composition of claim 1 , wherein the mipomersen is present in an amount less than, about equal to, or greater than an effective amount of mipomersen when administered as a monotherapy.

3. The composition of claim 1 , wherein the mipomersen comprises mipomersen nonadecasodium.

4. The composition of claim 1 , wherein the mipomersen is suspended in the eicosapentaenoic acid.

5. The composition of claim 1 , wherein the mipomersen is in the form of an injectable solution.

6. The composition of claim 1 , wherein the mipomersen is present in an amount of about 5 mg to about 2000 mg.

7. The composition of claim 1 , wherein the eicosapentaenoic acid is present in an amount of about 400 mg to about 5000 mg.

8. The composition of claim 1 , wherein the mipomersen is present in an amount of about 2 mg to about 10 mg and the eicosapentaenoic acid is present in an amount of about 400 mg to about 5000 mg.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Nov 19, 2020
From: CPPIB CREDIT EUROPE S.À R.L.
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 054484/0552 →
SECURITY INTEREST Recorded Dec 21, 2017
From: AMARIN PHARMACEUTICALS IRELAND LIMITED
To: CPPIB CREDIT EUROPE S.À R.L.
Reel/Frame 044938/0257 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2017
From: ZAKRZEWSKI, JOSEPH S.
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 041024/0815 →